- Home
- TRUE vs ENTA Comparison
TRUE vs ENTA Comparison
Compare TRUE & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUE
- ENTA
- Stock Information
- Founded
- TRUE 2005
- ENTA 1995
- Country
- TRUE United States
- ENTA United States
- Employees
- TRUE N/A
- ENTA N/A
- Industry
- TRUE Computer Software: Programming Data Processing
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- TRUE Technology
- ENTA Health Care
- Exchange
- TRUE Nasdaq
- ENTA Nasdaq
- Market Cap
- TRUE 114.6M
- ENTA 112.4M
- IPO Year
- TRUE 2014
- ENTA 2013
- Fundamental
- Price
- TRUE $1.45
- ENTA $5.93
- Analyst Decision
- TRUE Buy
- ENTA Buy
- Analyst Count
- TRUE 5
- ENTA 4
- Target Price
- TRUE $3.19
- ENTA $17.25
- AVG Volume (30 Days)
- TRUE 397.0K
- ENTA 119.2K
- Earning Date
- TRUE 05-05-2025
- ENTA 05-12-2025
- Dividend Yield
- TRUE N/A
- ENTA N/A
- EPS Growth
- TRUE N/A
- ENTA N/A
- EPS
- TRUE N/A
- ENTA N/A
- Revenue
- TRUE $179,356,000.00
- ENTA $64,462,999.00
- Revenue This Year
- TRUE $7.54
- ENTA N/A
- Revenue Next Year
- TRUE $11.02
- ENTA N/A
- P/E Ratio
- TRUE N/A
- ENTA N/A
- Revenue Growth
- TRUE 10.18
- ENTA N/A
- 52 Week Low
- TRUE $1.05
- ENTA $4.09
- 52 Week High
- TRUE $4.62
- ENTA $17.24
- Technical
- Relative Strength Index (RSI)
- TRUE 44.81
- ENTA 55.39
- Support Level
- TRUE $1.46
- ENTA $5.55
- Resistance Level
- TRUE $1.65
- ENTA $6.23
- Average True Range (ATR)
- TRUE 0.12
- ENTA 0.33
- MACD
- TRUE 0.00
- ENTA 0.05
- Stochastic Oscillator
- TRUE 14.71
- ENTA 75.31
About TRUE TrueCar Inc.
TrueCar Inc is a data-driven online platform operating on common technology infrastructure, powered by proprietary data and analytics. It also customizes and operates its platform for affinity group marketing partners, including financial institutions like PenFed and American Express; membership-based organizations like Consumer Reports, AARP, Sam's Club, and AAA; and employee buying programs for large enterprises such as IBM and Walmart. The Company has one operating segment, with three distinct service offerings: Dealer products and services, OEM incentives, and other.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.